Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis.
Taşkıran E, Terzi M, Helvacı EM, Eser MZ, Avcı B, Ömer Faruk T, Yetkin MF, Çilingir V, Bir LS, Kabay SC, Bilge N, Poyraz T, Demir CF, Dündar DK, Ocak Ö, Çam M, Mavioğlu H, Altun Y, Karaibrahimoğlu A. Taşkıran E, et al. Among authors: demir cf. Mult Scler Relat Disord. 2024 Mar;83:105391. doi: 10.1016/j.msard.2023.105391. Epub 2024 Jan 27. Mult Scler Relat Disord. 2024. PMID: 38335838
348 results